Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Long-Term Debt Issuances (2016 - 2021)

Historic Long-Term Debt Issuances for Sunshine Biopharma (SBFM) over the last 8 years, with Q3 2021 value amounting to $1.4 million.

  • Sunshine Biopharma's Long-Term Debt Issuances rose 16838.64% to $1.4 million in Q3 2021 from the same period last year, while for Dec 2021 it was $3.3 million, marking a year-over-year increase of 9820.86%. This contributed to the annual value of $3.3 million for FY2021, which is 9820.86% up from last year.
  • Sunshine Biopharma's Long-Term Debt Issuances amounted to $1.4 million in Q3 2021, which was up 16838.64% from $768500.0 recorded in Q2 2021.
  • Sunshine Biopharma's Long-Term Debt Issuances' 5-year high stood at $1.4 million during Q3 2021, with a 5-year trough of $25000.0 in Q2 2018.
  • Its 5-year average for Long-Term Debt Issuances is $394378.0, with a median of $216000.0 in 2017.
  • In the last 5 years, Sunshine Biopharma's Long-Term Debt Issuances plummeted by 8190.87% in 2018 and then soared by 142936.23% in 2020.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Long-Term Debt Issuances stood at $256121.0 in 2017, then tumbled by 30.89% to $177000.0 in 2018, then tumbled by 63.15% to $65230.0 in 2019, then skyrocketed by 1429.36% to $997603.0 in 2020, then skyrocketed by 40.34% to $1.4 million in 2021.
  • Its Long-Term Debt Issuances stands at $1.4 million for Q3 2021, versus $768500.0 for Q2 2021 and $1.2 million for Q1 2021.